Clinical Trial Update: A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that AC Immune's Alzheimer’s-focused candidate ACI-24.060 is being evaluated in Phase 1 and Phase 2 studies for Alzheimer's…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Down Syndrome

Drugs mentioned

• ACI-24.060

Snippet

Sponsor: AC Immune SA | Conditions: Amyloid Plaque, Beta-Amyloid | Phase 1, Phase 2 | Status: RECRUITING